Reckitt Sells Skin-Care Brand E45 To Karo In £200m Deal

Karo Pharma is poised to expand its portfolio in the UK with the acquisition of leading skin-care brand E45 from Reckitt.

Acquisition
• Source: Shutterstock

Reckitt Benckiser Group plc is set to divest skin-care brand E45 to Sweden’s Karo Pharma Aktiebolag in a deal worth £200m ($271m).

Subject to the satisfaction of customary closing conditions – including consultation with employee representatives in France – the proposed sale...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United Kingdom

More from Europe